MedTrace Logo

Paper Applicator Acceptability Study

NCT02179138 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2015-04-10

No results posted yet for this study

Summary

To assess the acceptability of a user-filled, paper, applicator for delivery of tenofovir (TFV) gel among women at high risk of acquiring human immunodeficiency virus (HIV) in rural KwaZulu-Natal, South Africa.

Conditions

  • HIV Prevention

Interventions

DRUG

TFV 1% gel

Sponsors & Collaborators

  • CONRAD

    lead OTHER

Principal Investigators

  • Leila E Mansoor, Ph.D. · Centre for the AIDS Programme of Research in South Africa

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Primary Completion
2015-03-31

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02179138 on ClinicalTrials.gov